Merck Free Cash Flow 2010-2024 | MRK

Merck free cash flow for the twelve months ending December 31, 2024 was , a year-over-year.

  • Merck annual free cash flow for 2024 was $18.096B, a 97.92% increase from 2023.
  • Merck annual free cash flow for 2023 was $9.143B, a 37.83% decline from 2022.
  • Merck annual free cash flow for 2022 was $14.707B, a 69.55% increase from 2021.

Merck Free Cash Flow 2010-2024 | MRK

  • Merck annual free cash flow for 2024 was $18.096B, a 97.92% increase from 2023.
  • Merck annual free cash flow for 2023 was $9.143B, a 37.83% decline from 2022.
  • Merck annual free cash flow for 2022 was $14.707B, a 69.55% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$823.1B
Johnson & Johnson (JNJ)$380.1B
Novo Nordisk (NVO)$374.3B
AbbVie (ABBV)$348.4B
Roche Holding AG (RHHBY)$259.5B
Novartis AG (NVS)$218.5B
Pfizer (PFE)$146.7B
Sanofi (SNY)$136B
Bayer (BAYRY)$22B
Innoviva (INVA)$1.1B